Many people believe artificial intelligence is at an inflection point, driven by accelerating advancements and rapid adoption. Ark Investment Management estimates that revenue from AI could reach $14
If you're looking for some explosive returns in the stock market, you might want to consider betting on short-squeeze stocks. These stocks have a high percentage of their float sold short by hedge fun

Is Upstart Stock a Buy?

05:59am, Wednesday, 19'th Apr 2023
Upstart's tech-enabled lending platform has tremendous potential. Upstart's risks came into the limelight in 2022.
If you are looking for some excitement in your portfolio, you might be tempted by high-risk, high-reward stocks. These are the stocks that can soar to the moon or crash to the ground, depending on how
SAN MATEO, Calif.--(BUSINESS WIRE)--Upstart to Report First Quarter 2023 Earnings on May 9, 2023
The company isn't quite tapping into its massive market opportunity yet. The lending market isn't looking great right now.
Although the concept of gambling on short-squeeze stocks present risks, certain market ideas drive hedge funds crazy. By this statement, I'm referring to companies that speculators believe in their he
Upstart runs a risk evaluation service for lending partners that want to find creditworthy borrowers who happen to have bad FICO scores. Shares of Upstart have plummeted around 95% from a peak they se

2 Risky Tech Stocks to Avoid

08:50am, Friday, 14'th Apr 2023
Betting on comebacks can be lucrative but doesn't always work out. Coinbase has seen revenue collapse and losses balloon as crypto trading volumes evaporate.
Nvidia's massive AI opportunity could help the stock soar in the next five years. Upstart is on track to take advantage of growing adoption of AI in banking and lending services, and shares are tradin

Why Shares of Upstart Are Falling Today

02:44pm, Wednesday, 12'th Apr 2023
Inflation is showing signs of slowing. Analysts at JPMorgan are not bullish on Upstart.
Yahoo Finance Live anchors Julie Hyman and Brad Smith discuss a JPMorgan analyst's Underweight rating on Upstart stock.
Upstart's business thrived in 2021, when interest rates were low. But last year, as the Fed aggressively raised rates, Upstart struggled significantly.
At one point in 2021, Upstart traded at close to $400 per share. Now the stock trades at around $17.
Even another market downturn could present opportunities for long-term investors. Vertex Pharmaceuticals isn't slowing down, but more growth opportunities could be on the near horizon.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE